OPEN ACCESS POLICY
Journal of Chronotherapy and Drug Delivery is an open access journal, which means that all contents are freely available without any charge to the user or his/her institution. The users are freely allowed to read, download, copy, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author but not for any type of commercial use. This is in accordance with The Budapest Open Access Initiative (BOAI) definition of open access.
Journal of Chronotherapy and Drug Delivery follows a strong plagiarism policy. It ensures that none of the part of manuscript is plagiarized from other sources and proper reference is provided for all contents extracted from other sources. Self-plagiarism, in which the authors use their own previously published work without proper citation, is also not acceptable.
PEER REVIEW POLICY
All manuscripts submitted for possible publication in Journal of Chronotherapy and Drug Delivery are peer reviewed following the procedure outlined below:
Initially, the editors first evaluate all manuscripts submitted. At this stage, papers that are insufficiently original, having serious scientific flaws, poor in grammar or English language, falling outside the aims and scope of the journal will get rejected. Those manuscripts which meet the minimum criteria are forwarded to at least two experts for review.
Journal of Chronotherapy and Drug Delivery follows a double blind reviewing, where the reviewers remains anonymous throughout the process. The reviewers are selected on the basis of their area of expertise as per our database. The reviewer is asked to evaluate the manuscript with respect to its originality, significance, ethical guidelines or protocols, methodology, presentation of results, appropriate references and report.
The time required for the review process depends upon the availability and the response of the reviewer. Revised manuscripts might be returned to the initial referees who may then request another revision of a manuscript, if needed.
A final decision to accept or reject the manuscript will be sent to the author along with any recommendations made by the referees. The decision of Editor-in-Chief is final to accept or reject the article.